Princeton Biomeditech Corp
South Brunswick Township, NJ Doing business as P B M
- UEI
- KWPPNEUVY865
- CAGE
- 0ZWY6
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 4242 US-1, Monmouth Junction, NJ 08852, USA
- Website
- pbmc.com
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | -$37,628 |
| FY2023 | $28,728,000 |
Contract vehicles
No active vehicles.
1 expired vehicle
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Ihealth Labs Inc. | Sunnyvale, CA | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Visby Medical, Inc. | San Jose, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Now Diagnostics | Springdale, AR | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Celltrion USA Inc. | Jersey City, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Maxim Biomedical, Inc. | Rockville, MD | 325413 In-Vitro Diagnostic Substance Manufacturing |
About the company
Princeton Biomeditech Corp, doing business as P B M, is a manufacturer of rapid, point of care diagnostics including over 70 different one-step tests for consumer in-home use and professional on-site use.
Princeton Biomeditech has been awarded over $50 million in federal contracts from 2021-2023 to provide COVID-19 tests, multiplex COVID-19 and influenza assays, readers for rapid testing, and expand industrial base capacity for critical pandemic preparedness medical supplies. Contracting agencies include the Department of Health and Human Services, National Institutes of Health, and Department of the Air Force. Awards utilized firm fixed price and definitive contract types to support development, production and delivery of coronavirus diagnostics. Place of performance spanned New Jersey, Georgia and the contractor's headquarters. No set aside designations were indicated.
SBA capabilities narrative
HEALTH CARE - RAPID POINT-OF-CARE DIAGNOSTIC TEST KITS. ONE-STEP PREGNANCY; OVULATION; DRUGS OF ABUSE DETECTION; INFECTIOUS DISEASES - STREP A, RUBELLA, MONO, H. PYLORI, E. COLI, SALMONELLA; CARDIAC MARKERS - TROPONIN I, MYOGLOBIN, CK-MB; VETERINARY DX.
Quick answers
Is Princeton Biomeditech Corp registered in SAM.gov?
Yes. Princeton Biomeditech Corp's SAM.gov registration is active through February 24, 2027.
Which contract vehicles does Princeton Biomeditech Corp hold?
Princeton Biomeditech Corp holds a place on 1 federal contract vehicle: FSS-65-VII.
How much has Princeton Biomeditech Corp received in federal contracts?
Federal contracts obligated $28,690,372 to Princeton Biomeditech Corp in fiscal years 2023 through 2027.
What is Princeton Biomeditech Corp's most recent federal award?
Princeton Biomeditech Corp's most recent federal contract award is Over the counter (OTC) covid-19 tests (75A50223C00045), from Office of the Assistant Secretary for Preparedness and Response, on September 20, 2023.
On GovTribe
See Princeton Biomeditech Corp's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors